A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter pylori Eradication: A Prospective Randomized Trial [Corrigendum]

Benzer Materyaller

• A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
  Yazar:: Tai, Wei-Chen, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials
  Yazar:: Lin, Lien-Chieh, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
  Yazar:: Gisbert, Javier P, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• High dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections
  Yazar:: Attumi, Taraq A., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Is concomitant quadruple therapy for Helicobacter pylori eradication really needed for Japanese patients?
  Yazar:: Francesco, Vincenzo De, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)